By Fineline Cube 
China-based Chia Tai Tianqing Pharmaceutical has entered into a Named Patient Program (NPP) collaboration with the Greater China Cancer Foundation. This partnership aims to provide innovative treatment solutions for patients with urgent medical needs in Hong Kong.
NPP Mechanism
The NPP in Hong Kong is a special mechanism designed to assist patients in urgent need of medication. It allows access to drugs that are either under development or have been marketed but have not yet obtained local marketing approval. This program enables clinicians to provide necessary treatment to patients in a manner that complies with legal and ethical standards, even before the drug is commercially available.
Impact and Benefits
Through this collaboration, Chia Tai Tianqing and the Greater China Cancer Foundation are committed to addressing the critical needs of patients facing life-threatening conditions. The NPP ensures that patients can receive potentially life-saving treatments without unnecessary delays, bridging the gap between drug development and commercialization.-Fineline Info & Tech